METHYLPHENIDATE RITAL ADHD:
METHYLPHENIDATE ADHD SYNDROME (MPS-D) is a developmental disorder of the central nervous system, which affects intellectual, psychomotor and speech functioning in children. MPS-D is caused by mutations in the gene for the enzyme tyrosine hydroxylase, which is involved in the breakdown of dopamine.
In those who have the affected form of the gene, tyrosine (which is the main building block of dopamine) cannot be degraded in the body, leading to the accumulation of dopamine in the brain.
This is the most common form of childhood-onset ADHD. There are other forms of the condition, such as (METHYLPHENIDATE ADHD CLODGED-CYLPHENIDATE) which is due to problems with other enzymes.
The diseases can manifest from different points in a person’s childhood. Individuals are born with the ability to metabolize dopamine but their DNA does not allow them to break it down quickly enough. In terms of our patient it has allowed us to help them to retain this form of cognitive function. We are delighted with the outcomes and it gives us the option to use this oral form of methylphenidate rather than the intravenous route.